Plazomicin Sulfate

CHEMBL2364623 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
690.8 g/mol
LogP
Phase
4

A sulfate salt form of plazomicin with the same therapeutic properties. A newer aminoglycoside antibiotic designed to treat serious, difficult-to-treat bacterial infections including those caused by antibiotic-resistant bacteria such as carbapenem-resistant Enterobacteriaceae.

Moleküler Ağırlık

690,8000 g/mol

TPSA

352,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CCN)OC[C@]1(C)O.O=S(=O)(O)O

InChI

InChI=1S/C25H48N6O10.H2O4S/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32;1-5(2,3)4/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36);(H2,1,2,3,4)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+;/m1./s1

Molecular Formula

C25H50N6O14S

HBD / HBA

13 / 19

Döndürülebilir Bağlar

13

Ağır Atomlar

46

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A sulfate salt form of plazomicin with the same therapeutic properties. A newer aminoglycoside antibiotic designed to treat serious, difficult-to-treat bacterial infections including those caused by antibiotic-resistant bacteria such as carbapenem-resistant Enterobacteriaceae.

Yes, Plazomicin Sulfate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2364623. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71515458. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.